The North America Synoptophore Market would witness market growth of 6.3% CAGR during the forecast period (2020-2026).
The synoptophore flexibility and precision in conducting thorough binocular vision evaluation, utilized in diagnosis and management of strabismus and amblyopia have expanded the rate of adoption in various ophthalmic centers. The significant binocular measurements, for example, the angle of deviation (subjective/objective), strange retinal correspondence, angle kappa, and stereopsis can be rapidly and easily performed utilizing a synoptophore.
Increasing awareness about the early determination of amblyopia and strabismus to prevent surgical intervention, later on, has prompted a few schools and universities to organize thorough eye assessment camps upheld by public and private companies. The reliability and reproducibility of synoptophore in appraisals of these ocular motility issues make them an indispensable part of eye assessment methods boosting the market development.
Synoptophore is normally utilized in the diagnosis of ocular muscular imbalance through simultaneous perception, sensory and motor fusion, and stereopsis tests. Notwithstanding, the accessibility of choices, for example, photo screen and prism cover test that are less complicated, compliance of the patient, and cost-effectiveness in the diagnosis of amblyopia and strabismus have obstructed the development of the segment. For example, in 2016 a handheld gadget called Pediatric Vision Scanner (PVS) was cleared by the FDA that demonstrated 95% precision in the diagnosis of amblyopia and strabismus.
Based on Application, the market is segmented into Diagnostic and Therapeutic. Based on Type, the market is segmented into Manual and Automated. Based on End-user, the market is segmented into Clinics, Hospitals and Other End-users. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Metall Zug AG (Haag-Streit AG), Takagi Seiko Co., Ltd., Oculus Optikgerate GmbH, Appasamy Associates Pvt. Ltd., Prkamya Visions, 66 Vision Tech Co., Ltd., Nanjing Redsun Optical Co., Ltd., Gem Optical Instruments Industries, and Shanghai Link Instruments Co., Ltd.
Scope of the Study
Market Segmentation:
By Application
• Diagnostic
• Therapeutic
By Type
• Manual
• Automated
By End User
• Clinics
• Hospitals
• Other End-users
By Country
• US
• Canada
• Mexico
• Rest of North America
Companies Profiled
• Metall Zug AG (Haag-Streit AG)
• Takagi Seiko Co., Ltd.
• Oculus Optikgerate GmbH
• Appasamy Associates Pvt. Ltd.
• Prkamya Visions
• 66 Vision Tech Co., Ltd.
• Nanjing Redsun Optical Co., Ltd.
• Gem Optical Instruments Industries
• Shanghai Link Instruments Co., Ltd.
Unique Offerings
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
Our reports have been used by over 10K customers, including:
The global immunofluorescence assays market is projected to reach USD 3.5 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 6.0% during the forecast period. The growth in this market is primarily attributed to the increasing prevalence of chronic diseases and rising R&D spending & healthcare expenditure. Emerging markets are expected...
The North America organoids market is expected to reach US$ 1,406.47 million by 2027 from US$ 291.39 million in 2019. The market is anticipated to grow at a CAGR of 21.7% from 2020 to 2027. Growth of the North America organoids market is attributed to emergence of three-dimensional (3D) organoids and rise in investments in research. However,...
The global organoids market is expected to reach US$ 3,420.40 million by 2027 from US$ 689.47 million in 2019. The market is estimated to grow at a CAGR of 22.1% from 2020 to 2027. Increasing demand for tumor modelling and biobanking, rising adoption of personalized drugs, and growing focus on developing alternatives for animal testing...
An organ-on-a-chip is a microfluidic cell culture device that contains continuously perfused chambers. This chip develops a narrow channel for the blood and airflow in organs, such as the lung, gut, liver, heart, and other organs. Such devices produce multiple levels of tissue and organ functionalities, which are not feasible using conventional...
573 pages •
By Global Industry Analysts
• Oct 2020
Looking Beyond Today’s Challenges to Tomorrow’s Healthcare Needs. Genetic Testing to Reach $18.9 Billion as the Burden of Non-Communicable Diseases Grows Bigger
The global market for Genetic Testing is forecast to reach US$18.9 billion by the year 2027, trailing a post COVID-19 CAGR of 8.6% over the analysis period 2020 through 2027....
Summary SomaLogic Inc (SomaLogic) is a life science company that discovers, develops and commercializes life science research tools and clinical diagnostic products.The company’s products include SOMAscan assay and SOMAmer reagents. Its SOMAscan reagents is a proteomic platform that combines the properties of antibodies...
No air: Demand for industry services has declined as a result of the closure of nonessential businesses Abstract Air Duct Cleaning Services in the US Operators in this industry provide air duct cleaning services to buildings and dwellings. This includes the cleaning of heating and cooling system components. This...
Healthy future: Despite the mounting likelihood of new regulation, industry revenue will likely grow Abstract Cryogenic Biobanking Services Since the landmark scientific achievement of human genome sequencing in 2003, the Cryogenic Biobanking Services industry is increasingly viewed as the link between...
Abstract Fleet Telematics Systems Procurement in the US This report is intended to assist buyers of fleet telematics systems. Fleet telematics systems are used to monitor, map and track vehicle fleets in the field. Digital maps and Global Positioning System (GPS) technology allow for real-time visualization...
On the rebound: Medicare reimbursement caps for physical therapy may constrain revenue growth Abstract Physical Therapists in the US Over the five years to 2019, the role of physical therapy in promoting health and wellness has increased, benefiting this industry. As the number of individuals aged...
Healthcare
Health Services
Health Insurance
Pathology
Insurance
United States
North America
Elderly Population
Disposable Income
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.